Cramer's Lightning Round - BioMarin Deserves To Be Higher (7/14/14)

by: Miriam Metzinger

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Monday July 14.

Bullish Calls:

  • BioMarin (NASDAQ:BMRN): "The stock is too low. It has not kept pace with the others, and it deserves to be higher."
  • Isis Pharmaceuticals (ISIS), Seattle Genetics (NASDAQ:SGEN): Cramer prefers these to Puma Biotechnology.
  • Apache (NYSE:APA): "It is the overlooked independent oil. I like that stock so much. If you own it, I would buy more."

Bearish Calls:

  • Whole Foods (NASDAQ:WFM): "Here's the problem. We need to see a few quarters in a row ... it is too expensive if it is seeing not-so-good earnings. I would love to say 'buy it,' but I have to wait."
  • Puma Biotechnology (NYSE:PBYI): Cramer prefers Isis Pharmaceuticals and Seattle Genetics.


Jim Cramer’s Action Alerts PLUS: Check out Cramer’s multi-million dollar charitable trust portfolio and uncover the stocks he thinks could be HUGE winners. Start your FREE 14-day trial now!

Get Cramer's Picks by email - it's free and takes only a few seconds to sign up.